| # | Drug | Count |
|---|---|---|
| 0 | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | 74 |
| 1 | BEVACIZUMAB | 58 |
| 2 | OXALIPLATIN | 37 |
| 3 | FLUOROURACIL | 35 |
| 4 | FLUOROURACIL CREAM, 0.5% | 35 |
| 5 | LETROZOLE | 31 |
| 6 | LETROZOLE TABLETS | 31 |
| 7 | CARBOPLATIN | 30 |
| 8 | CAPECITABINE | 29 |
| 9 | PACLITAXEL | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AIR POLYMER-TYPE A INTRAUTERINE FOAM | 1 | 0.5000 |
| 1 | 3% SODIUM CHLORIDE | 1 | 0.0088 |
| 2 | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | 74 | 0.0024 |
| 3 | DEXRAZOXANE FOR INJECTION | 2 | 0.0021 |
| 4 | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | 15 | 0.0018 |
| 5 | DOSTARLIMAB | 4 | 0.0016 |
| 6 | IBANDRONATE SODIUM | 5 | 0.0016 |
| 7 | EXEMESTANE | 20 | 0.0009 |
| 8 | UREA | 2 | 0.0009 |
| 9 | TOPOTECAN | 5 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 78 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 62 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 60 |
| 3 | Aromatase Inhibitor [EPC] | 53 |
| 4 | Kinase Inhibitor [EPC] | 53 |
| 5 | Corticosteroid [EPC] | 50 |
| 6 | Microtubule Inhibitor [EPC] | 40 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
| 8 | Proton Pump Inhibitor [EPC] | 22 |
| 9 | Loop Diuretic [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 1 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 2 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 3 | Vitamin D2 Analog [EPC] | 4 | 0.0006 |
| 4 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 5 | Aromatase Inhibitor [EPC] | 53 | 0.0005 |
| 6 | Paramagnetic Contrast Agent [EPC] | 2 | 0.0004 |
| 7 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 8 | Epidermal Growth Factor Receptor Antagonist [EPC] | 17 | 0.0004 |
| 9 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |